Cambodia Eyes Approval for India-Made Dengue Vaccine for Ages 4-60
Health

Cambodia Eyes Approval for India-Made Dengue Vaccine for Ages 4-60

Cambodia is set to consider the approval of India's first dengue vaccine, QDENGA, manufactured by Takeda Biopharmaceuticals India. Approved for individuals aged 4-60, regardless of prior infection, the vaccine is expected to bolster dengue prevention efforts.

This article requires PRO

This article is outside the free access window or is a special report. PRO unlocks it and the full archive.